Biotech IDEAYA Biosciences Announces US FDA IND-Clearance for IDE849, a Potential First-in-Class DLL3 TOP1 ADC, for a Phase 1 Study in Solid Tumors May 6, 2025
Biotech IDEAYA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update May 6, 2025
Biotech IND Application for NTS071, Nutshell Therapeutics’ p53 Y220C Allosteric Reactivator, Received US FDA clearance May 4, 2025
Biotech Pykus Therapeutics Announces Positive Interim Pilot Clinical Trial Results of PYK-2101, a Novel Retinal Sealant May 3, 2025
Biotech Nektar to Announce Financial Results for the First Quarter on Thursday, May 8, 2025, After Close of U.S.-Based Financial Markets May 2, 2025
Biotech Kodiak Sciences Data at ARVO 2025 Highlight Power and Versatility of ABC Platform in Addressing Complex Multifactorial Ocular Diseases May 2, 2025
Biotech Satsuma Pharmaceuticals Announces U.S. FDA Approval for Atzumi™ (Dihydroergotamine) Nasal Powder for the Acute Treatment of Migraine May 1, 2025
Search
Biotech
May 6, 2025
May 6, 2025
May 4, 2025
May 3, 2025
May 3, 2025
May 3, 2025
May 2, 2025
May 2, 2025
May 1, 2025
May 1, 2025
